Found: 55
Select item for more details and to access through your institution.
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.
- Published in:
- EP: Europace, 2024, v. 26, n. 7, p. 1, doi. 10.1093/europace/euae183
- By:
- Publication type:
- Article
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 5, p. 638, doi. 10.3390/healthcare11050638
- By:
- Publication type:
- Article
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.
- Published in:
- 2014
- By:
- Publication type:
- journal article
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
- Published in:
- Vascular Health & Risk Management, 2014, v. 10, p. 425, doi. 10.2147/VHRM.S63298
- By:
- Publication type:
- Article
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.
- Published in:
- Vascular Health & Risk Management, 2014, v. 10, p. 101, doi. 10.2147/VHRM.S55246
- By:
- Publication type:
- Article
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 3, p. 457, doi. 10.1111/bjh.15533
- By:
- Publication type:
- Article
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 4, p. 610, doi. 10.1111/bjh.14084
- By:
- Publication type:
- Article
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3040, doi. 10.1111/dom.15202
- By:
- Publication type:
- Article
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063479
- By:
- Publication type:
- Article
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER).
- Published in:
- Thrombosis Journal, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12959-019-0195-7
- By:
- Publication type:
- Article
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 4, p. 724, doi. 10.1111/bcp.12836
- By:
- Publication type:
- Article
German S3 guideline for the prevention of venous thromboembolism updated.
- Published in:
- VASA. Zeitschrift für Gefässkrankheiten, 2016, v. 45, n. 5, p. 347, doi. 10.1024/0301-1526/a000559
- By:
- Publication type:
- Article
Prothrombinase-Induced Clotting Time Assay for Determination of the Anticoagulant Effects of Unfractionated and Low-Molecular-Weight Heparins, Fondaparinux, and Thrombin Inhibitors.
- Published in:
- American Journal of Clinical Pathology, 2008, v. 130, n. 3, p. 446, doi. 10.1309/Q0G21Y26UR0UHQ1A
- By:
- Publication type:
- Article
Oral Direct Thrombin Inhibition: an Effective and Novel Approach for Venous Thromboembolism.
- Published in:
- Drugs, 2004, v. 64, n. 1, p. 7, doi. 10.2165/00003495-200464001-00003
- By:
- Publication type:
- Article
Oral Direct Thrombin Inhibition: an Effective and Novel Approach for Venous Thromboembolism.
- Published in:
- Drugs, 2004, v. 64, p. 7, doi. 10.2165/00003495-200464001-00003
- By:
- Publication type:
- Article
Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 5, p. 339, doi. 10.1111/j.1600-0609.2009.01230.x
- By:
- Publication type:
- Article
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
- Published in:
- JAMA Network Open, 2020, p. e200107, doi. 10.1001/jamanetworkopen.2020.0107
- By:
- Publication type:
- Article
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 199, doi. 10.1007/s40801-021-00289-w
- By:
- Publication type:
- Article
Strengths and limitations of standards of care to guide the orthopedic surgeon in VTE prevention.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Some Observations on the Prophylactic Recommendation.
- Published in:
- Deutsches Ärzteblatt International, 2017, v. 114, n. 7, p. 118, doi. 10.3238/arztebl.2017.0118b
- By:
- Publication type:
- Article
The Prophylaxis of Venous Thromboembolism.
- Published in:
- Deutsches Ärzteblatt International, 2016, v. 113, n. 31/32, p. 532, doi. 10.3238/arztebl.2016.0532
- By:
- Publication type:
- Article
European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02314-7
- By:
- Publication type:
- Article
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1405, doi. 10.1002/clc.23452
- By:
- Publication type:
- Article
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
- Published in:
- Clinical Cardiology, 2016, v. 39, n. 10, p. 565, doi. 10.1002/clc.22565
- By:
- Publication type:
- Article
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 3, p. 203, doi. 10.2165/00003088-200847030-00006
- By:
- Publication type:
- Article
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164076
- By:
- Publication type:
- Article
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2022886, doi. 10.1001/jamanetworkopen.2020.22886
- By:
- Publication type:
- Article
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
- Published in:
- International Journal of Stroke, 2020, v. 15, n. 3, p. 308, doi. 10.1177/1747493019891516
- By:
- Publication type:
- Article
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 2, p. 312, doi. 10.1007/s11239-023-02895-7
- By:
- Publication type:
- Article
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 2, p. 267, doi. 10.1007/s11239-020-02180-x
- By:
- Publication type:
- Article
New oral Xa and IIa inhibitors: updates on clinical trial results.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2008, v. 25, n. 1, p. 52, doi. 10.1007/s11239-007-0108-7
- By:
- Publication type:
- Article
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
- Published in:
- Clinical Research in Cardiology, 2023, v. 112, n. 6, p. 759, doi. 10.1007/s00392-022-02079-y
- By:
- Publication type:
- Article
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.
- Published in:
- European Heart Journal Open, 2023, v. 3, n. 3, p. 1, doi. 10.1093/ehjopen/oead051
- By:
- Publication type:
- Article
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
- Published in:
- European Heart Journal, 2016, v. 37, n. 38, p. 2882, doi. 10.1093/eurheartj/ehw233
- By:
- Publication type:
- Article
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
- Published in:
- European Heart Journal, 2016, v. 37, n. 14, p. 1145, doi. 10.1093/eurheartj/ehv466
- By:
- Publication type:
- Article
Continued commitment to safety: building on the existing rivaroxaban knowledge base.
- Published in:
- European Heart Journal, 2015, v. 17, p. D21, doi. 10.1093/eurheartj/suv038
- By:
- Publication type:
- Article
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2016, v. 22, n. 2, p. 138, doi. 10.1177/1076029615607303
- By:
- Publication type:
- Article
Benefits and Risks of Preventing Thromboembolism With Enoxaparin in Patients With General Surgery in Real World—The CLEVER Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2013, v. 19, n. 3, p. 282, doi. 10.1177/1076029612461067
- By:
- Publication type:
- Article
Prevention of Venous Thromboembolism Using Enoxaparin in Day Surgery: Results of the SMART Noninterventional Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 3, p. 265, doi. 10.1177/1076029611425379
- By:
- Publication type:
- Article
Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 2, p. 159, doi. 10.1177/1076029611433769
- By:
- Publication type:
- Article
Anticoagulation: The Present and Future.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2001, v. 7, n. 3, p. 195, doi. 10.1177/107602960100700303
- By:
- Publication type:
- Article
Prevention of Venous Thromboembolism: Recommendations Based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2001, v. 7, n. 3, p. 174, doi. 10.1177/107602960100700301
- By:
- Publication type:
- Article
Heparin-Induced Thrombocytopenic Potential of GAG and Non-GAG-Based Antithrombotic Agents.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 1999, v. 5, n. 1S, p. S56, doi. 10.1177/10760296990050S110
- By:
- Publication type:
- Article